> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# AstraZeneca Hold Lifted on Covid Vaccine Trial
- URL: https://www.fdaweb.com/astrazeneca-hold-lifted-on-covid-vaccine-trial/
- Published: 2020-10-26T12:00:00.000Z
- Updated: 2026-09-14T16:33:55.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147954

FDA has lifted a clinical hold against AstraZeneca and the University of Oxford to resume clinical trials of their coronavirus vaccine, AZD1222\. The hold was [imposed](https://www.fdaweb.com/astrazeneca-covid-19-trial-stops-over-safety-signal/) in September after Oxford had said a patient’s neurological problem was detected, but it was likely not related to the vaccine. Clinical trials had resumed in the UK, Brazil, and South Africa, while the hold remained in effect in the U.S.

“Results from the late-stage trials are anticipated later this year, depending on the rate of infection within the communities where the clinical trials are being conducted,” AstraZeneca says. “Data readouts will be submitted to regulators and published in peer-reviewed scientific journals. Rolling reviews of the vaccine program have already begun in countries where this regulatory pathway has been established, providing regulators access to data as soon as they become available.”